These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 17977729

  • 1. Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.
    Sugimoto T, Itagaki K, Irie K.
    Bioorg Med Chem; 2008 Jan 15; 16(2):650-7. PubMed ID: 17977729
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity.
    Bögi K, Lorenzo PS, Szállási Z, Acs P, Wagner GS, Blumberg PM.
    Cancer Res; 1998 Apr 01; 58(7):1423-8. PubMed ID: 9537243
    [Abstract] [Full Text] [Related]

  • 6. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
    Wang QJ, Fang TW, Yang D, Lewin NE, Van Lint J, Marquez VE, Blumberg PM.
    Mol Pharmacol; 2003 Dec 01; 64(6):1342-8. PubMed ID: 14645664
    [Abstract] [Full Text] [Related]

  • 7. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
    Chen J, Deng F, Li J, Wang QJ.
    Biochem J; 2008 Apr 15; 411(2):333-42. PubMed ID: 18076381
    [Abstract] [Full Text] [Related]

  • 8. Indolactam-V is involved in the CH/pi interaction with Pro-11 of the PKCdelta C1B domain: application for the structural optimization of the PKCdelta ligand.
    Nakagawa Y, Irie K, Yanagita RC, Ohigashi H, Tsuda K.
    J Am Chem Soc; 2005 Apr 27; 127(16):5746-7. PubMed ID: 15839646
    [Abstract] [Full Text] [Related]

  • 9. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1.
    Lorenzo PS, Bögi K, Hughes KM, Beheshti M, Bhattacharyya D, Garfield SH, Pettit GR, Blumberg PM.
    Cancer Res; 1999 Dec 15; 59(24):6137-44. PubMed ID: 10626804
    [Abstract] [Full Text] [Related]

  • 10. Structural basis of RasGRP binding to high-affinity PKC ligands.
    Rong SB, Enyedy IJ, Qiao L, Zhao L, Ma D, Pearce LL, Lorenzo PS, Stone JC, Blumberg PM, Wang S, Kozikowski AP.
    J Med Chem; 2002 Feb 14; 45(4):853-60. PubMed ID: 11831896
    [Abstract] [Full Text] [Related]

  • 11. Alkyl cinnamates as regulator for the C1 domain of protein kinase C isoforms.
    Mamidi N, Gorai S, Sahoo J, Manna D.
    Chem Phys Lipids; 2012 Apr 14; 165(3):320-30. PubMed ID: 22414757
    [Abstract] [Full Text] [Related]

  • 12. Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase C epsilon and eta.
    Nakagawa Y, Irie K, Yanagita RC, Ohigashi H, Tsuda K, Kashiwagi K, Saito N.
    J Med Chem; 2006 May 04; 49(9):2681-8. PubMed ID: 16640328
    [Abstract] [Full Text] [Related]

  • 13. The nature of the hydrophobic n-alkanol binding site within the C1 domains of protein kinase Calpha.
    Slater SJ, Malinowski SA, Stubbs CD.
    Biochemistry; 2004 Jun 15; 43(23):7601-9. PubMed ID: 15182202
    [Abstract] [Full Text] [Related]

  • 14. New bivalent PKC ligands linked by a carbon spacer: enhancement in binding affinity.
    Sridhar J, Wei ZL, Nowak I, Lewin NE, Ayres JA, Pearce LV, Blumberg PM, Kozikowski AP.
    J Med Chem; 2003 Sep 11; 46(19):4196-204. PubMed ID: 12954072
    [Abstract] [Full Text] [Related]

  • 15. Kinetic analysis of the interaction of the C1 domain of protein kinase C with lipid membranes by stopped-flow spectroscopy.
    Dries DR, Newton AC.
    J Biol Chem; 2008 Mar 21; 283(12):7885-93. PubMed ID: 18187412
    [Abstract] [Full Text] [Related]

  • 16. Calorimetric study of the interaction of the C2 domains of classical protein kinase C isoenzymes with Ca2+ and phospholipids.
    Torrecillas A, Laynez J, Menéndez M, Corbalán-García S, Gómez-Fernández JC.
    Biochemistry; 2004 Sep 21; 43(37):11727-39. PubMed ID: 15362857
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and structure-activity relationship of new isobenzofuranone ligands of protein kinase C.
    Baba Y, Ogoshi Y, Hirai G, Yanagisawa T, Nagamatsu K, Mayumi S, Hashimoto Y, Sodeoka M.
    Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2963-7. PubMed ID: 15125969
    [Abstract] [Full Text] [Related]

  • 18. Role of hydrophobic residues in the C1b domain of protein kinase C delta on ligand and phospholipid interactions.
    Wang QJ, Fang TW, Nacro K, Marquez VE, Wang S, Blumberg PM.
    J Biol Chem; 2001 Jun 01; 276(22):19580-7. PubMed ID: 11278612
    [Abstract] [Full Text] [Related]

  • 19. Structural basis of binding of high-affinity ligands to protein kinase C: prediction of the binding modes through a new molecular dynamics method and evaluation by site-directed mutagenesis.
    Pak Y, Enyedy IJ, Varady J, Kung JW, Lorenzo PS, Blumberg PM, Wang S.
    J Med Chem; 2001 May 24; 44(11):1690-701. PubMed ID: 11356104
    [Abstract] [Full Text] [Related]

  • 20. Development of diacyltetrol lipids as activators for the C1 domain of protein kinase C.
    Mamidi N, Gorai S, Mukherjee R, Manna D.
    Mol Biosyst; 2012 Apr 24; 8(4):1275-85. PubMed ID: 22301880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.